Perspective Therapeutics To Present Updated [212Pb]VMT-α-NET Data At AACR 2026

Perspective Therapeutics, Inc. (NYSE: CATX) has announced that updated data on its [212Pb]VMT-α-NET program will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, scheduled for April 17 to 22, 2026, in San Diego, CA. The company is focused on developing advanced radiopharmaceutical treatments for various cancers. Further details regarding clinical trial abstracts will be released by AACR on April 17, 2026.